Schwartz, PJ, Crotti, L, Insolia, R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol
2012; 5: 868–877.
Mizusawa, Y, Horie, M, Wilde, AA. Genetic and clinical advances in congenital long QT syndrome. Circ J
2014; 78: 2827–2833.
Abriel, H, Zaklyazminskaya, EV. Cardiac channelopathies: genetic and molecular mechanisms. Gene
2013; 517: 1–11.
Moss, AJ, Shimizu, W, Wilde, AA, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation
2007; 115: 2481–2489.
Barsheshet, A, Goldenberg, I, O-Uchi, J, et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome. Circulation
2012; 125: 1988–1996.
Schwartz, PJ, Crotti, L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation
2011; 124: 2181–2184.
Tester, DJ, Will, ML, Haglund, CM, Ackerman, MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm
2005; 2: 507–517.
Giudicessi, JR, Ackerman, MJ. Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res
2013; 161: 1–14.
Bartos, DC, Giudicessi, JR, Tester, DJ, et al. A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation. Heart Rhythm
2014; 11: 459–468.
Donger, C, Denjoy, I, Berthet, M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation
1997; 96: 2778–2781.
Schmitt, N, Calloe, K, Nielsen, NH, et al. The novel C-terminal KCNQ1 mutation M520R alters protein trafficking. Biochem Biophys Res Commun
2007; 358: 304–310.
Yasuda, K, Hayashi, G, Horie, A, Taketani, T, Yamaguchi, S. Clinical and electrophysiological features of Japanese pediatric long QT syndrome patients with KCNQ1 mutations. Pediatr Int
2008; 50: 611–614.
Neyroud, N, Denjoy, I, Donger, C, et al. Heterozygous mutation in the pore of potassium channel gene KvLQT1 causes an apparently normal phenotype in long QT syndrome. Eur J Hum Genet
1998; 6: 129–133.
Schwartz, PJ, Stramba-Badiale, M, Crotti, L, et al. Prevalence of the congenital long-QT syndrome. Circulation
2009; 120: 1761–1767.
Kapplinger, JD, Tester, DJ, Salisbury, BA, et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm
2009; 6: 1297–1303.
Chockalingam, P, Crotti, L, Girardengo, G, et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol
2012; 60: 2092–2099.
Vila, E, Badia, A. Chronic administration of oxprenolol and metoprolol attenuate sympathetic cardiovascular responses only in non-adrenalectomized pithed rats. J Auton Pharmacol
1995; 15: 393–402.
Guimaraes, S, Moura, D. Vascular adrenoceptors: an update. Pharmacol Rev
2001; 53: 319–356.
Abu-Zeitone, A, Peterson, DR, Polonsky, B, McNitt, S, Moss, AJ. Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol
2014; 64: 1352–1358.
Wilde, AA, Ackerman, MJ. Beta-blockers in the treatment of congenital long QT syndrome: is one beta-blocker superior to another?
J Am Coll Cardiol
2014; 64: 1359–1361.
Kang, CL, Yang, JG, Zhang, SY, et al. The novel HERG and KVLQT1 mutations in Chinese familial long QT syndrome. Chinese Journal of Cardiac Arrythmias
2001; 5: 135–138 (article in Chinese).
Liu, W, Yang, J, Hu, D, et al. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population. Hum Mutat
2002; 20: 475–476.
Liang, L, Du, ZD, Cai, LL, et al. A novel KCNQ1 mutation in Chinese with congenital long QT syndrome. Chinese Journal of Pediatrics
2003; 8–11 (article in Chinese).
Li, CL, Zhang, L, Hu, DY, et al. Clinical characteristics of 85 probands with long QT syndrome and an update of genetic study in China. Chinese Journal of Cardiac Arrythmias
2004; 6–12 (article in Chinese).
Li, P, Li, CL, Hu, DY, et al. The mutation scanning of KCNQ1 gene for 31 long QT syndrome families. Chinese Journal of Medical Genetics
2004; 48–51 (article in Chinese).
Du, R, Ren, FX, Yang, JG, et al. Relationship between congenital long QT syndrome and brugada syndrome gene mutation. Acta Academiae Medicinae Sinicae
2005; 289–294 (article in Chinese).
Liu, W, Hu, D, Li, P, et al. Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome. Chinese Journal of Internal Medicin
2006; 463–466 (article in Chinese).
Zhang, S, Yin, K, Ren, X, et al. Identification of a novel KCNQ1 mutation associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a Chinese family. BMC Med Genet
2008; 9: 24.
Wang, RR, Li, N, Zhang, YH, et al. Novel compound heterozygous mutations T2C and 1149insT in the KCNQ1 gene cause Jervell and Lange-Nielsen syndrome. Int J Mol Med
2011; 28: 41–46.